Headache and Facial Pain Center
Advanced care for all headache and facial pain conditions.
Chronic headaches and facial pain can have a debilitating effect on your quality of life, impacting everything from work, school, family responsibilities and social life. They can also be some of the most complex conditions to diagnose and treat. At the Henry Ford Headache and Facial Pain Center, we emphasize collaborative care. Our team of specialists work together to create a personalized care plan for your specific headache or facial pain condition.
Multidisciplinary care for headaches and facial pain
Our team includes fellowship-trained and United Council for Neurologic Subspecialties headache and facial pain experts, who collaborate with other specialists in the Henry Ford Medical Group, one of the nation’s largest and most experienced group practices. This includes:
- Other neurologists
- Interventional pain management specialists
- Anesthesiologists
- Addiction specialists
- Neurosurgeons
- Otolaryngologists
Advanced diagnosis and treatment for the most complex cases
We start with an extensive diagnosis process, which includes a complete medical history, a neurological exam and any neuroimaging that may be necessary. From there, we work with you to develop a personalized treatment plan. There have been significant advancements in the field of headache and facial pain medicine in recent years, and Henry Ford is at the forefront. We offer a comprehensive approach to treatment, which may include:
- Medications
- Interventional procedures
- Intravenous infusions delivered in urgent care setting
- Nerve blocks
- Botox® treatment
- Pain psychology therapies
- Physical therapy
- Integrative medicine
- Lifestyle modification
- Nutritional supplements and vitamin therapies
- Neurosurgical procedures
Advancing care through research
As an academic health system, we are actively involved in the study of the biological underpinnings of headache and facial pain medicine. We also incorporate the latest research and treatment options into our care plans, including anti-CGRP monoclonal antibodies for migraines and FDA approved devices for the treatment of migraine and cluster headaches.
